Latest news
Loading news…
Apertura Gene Therapy
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Newyork, Argyll and Bute, United Kingdom Founded 2021 11-50 employees For Profit
Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
17
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 17
Company Info
- Founded
- 2021
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 25
- HQ
- Newyork, Argyll and Bute, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 2.1
- Trend (30d)
- 6.3
- Trend (90d)
- 3.6
- Last leadership hire
- Jul 14, 2022
Key People at Apertura Gene Therapy
Chief Executive Officer
17
professional contacts at Apertura Gene Therapy
Contact execs at Apertura Gene Therapy →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Apertura Gene Therapy
Loading news…
FAQs about Apertura Gene Therapy
People who checked this page also checked these
Browse the full Acquirezy directory.